Visipaque and post procedural complication Patient Reports February 11, 2012

Visipaque Side Effects Report #4701444-0
Visipaque side effect was reported by a Consumer or non-health professional from on June 14, 2005. Female patient, 70 years of age, weighting 191.8 lb, was diagnosed with stent placement and was treated with Visipaque. After drug was administered, patient experienced the following side effects: post procedural complication, pulmonary oedema, renal failure acute, respiratory arrest. Visipaque dosage: 200 MG, SINGLE DOSE, I.V.. During the same period patient was treated with VANCOMYCIN. Patient was hospitalized. Patient recovered.

Visipaque Side Effects Report #4640998-X
Visipaque side effect was reported by a Consumer or non-health professional from on Apr 19, 2005. Male patient, 59 years of age, was diagnosed with intermittent claudication and was treated with Visipaque. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea, post procedural complication. Visipaque dosage: unknown. Patient recovered.

Visipaque Side Effects Report #5730690-2
Visipaque side effect was reported by a Pharmacist from UNITED STATES on May 05, 2008. Male patient, 62 years of age, weighting 200.0 lb, was diagnosed with diagnostic procedure and was treated with Visipaque. After drug was administered, patient experienced the following side effects: antibiotic level above therapeutic, nephritis interstitial, nephropathy toxic, post procedural complication, renal failure acute. Visipaque dosage: 50ML 2 PROCEDURES IV. Patient was hospitalized. Patient recovered.

Visipaque Side Effects Report #4844698-2
Visipaque side effect was reported by a Health Professional from UNITED STATES on Dec 01, 2005. Female patient, 72 years of age, weighting 140.0 lb, was diagnosed with coronary artery disease  and was treated with Visipaque. After drug was administered, patient experienced the following side effects: erythema, eye swelling, feeling abnormal, hot flush, post procedural complication. Visipaque dosage: 130 ML. Patient recovered.


Visipaque Side Effects Report #4707406-1
Visipaque side effect was reported by a Health Professional from ITALY on June 22, 2005. Male patient, 68 years of age, was diagnosed with congestive cardiomyopathy and was treated with Visipaque. After drug was administered, patient experienced the following side effects: accelerated idioventricular rhythm, arteriogram coronary abnormal, blood pressure decreased, fall , heart rate decreased, loss of consciousness, post procedural complication, respiratory arrest. Visipaque dosage: unknown. During the same period patient was treated with CARVEDILOL, CALCITRIOL, CALCIUM CARBONATE, POLYSTYRENE SULFONATE, EPOGEN. Patient recovered.

Visipaque Side Effects Report #5095495-7
Visipaque side effect was reported by a Health Professional from UNITED STATES on Sept 01, 2006. Male patient, weighting 236.0 lb, was diagnosed with catheterisation cardiac and was treated with Visipaque. After drug was administered, patient experienced the following side effects: flushing, post procedural complication, pruritus. Visipaque dosage: 116 ML IC. Patient recovered.

Visipaque Side Effects Report #4599044-9
Visipaque side effect was reported by a Consumer or non-health professional from on Feb 18, 2005. Female patient, 63 years of age, weighting 88.18 lb, was diagnosed with bile duct stone and was treated with Visipaque. After drug was administered, patient experienced the following side effects: pancreatitis, post procedural complication. Visipaque dosage: 40 ML, AS REQUIRED, INTRADUCTAL. During the same period patient was treated with CEFOPERAZONE, GABEXATE MESILATE, GLUCOSE. Patient died.

Visipaque Side Effects Report #4615902-0
Visipaque side effect was reported by a Consumer or non-health professional from on Mar 07, 2005. Female patient, 63 years of age, weighting 88.18 lb, was diagnosed with bile duct stone and was treated with Visipaque. After drug was administered, patient experienced the following side effects: pancreatitis, post procedural complication. Visipaque dosage: 40 ML, SINGLE DOSE, INTRADUCTAL. During the same period patient was treated with CEFOPERAZONE, GABEXATE MESILATE, GLUCOSE. Patient died on 09/13/2002.

Visipaque Side Effects Report #4731749-9
Visipaque side effect was reported by a Pharmacist from UNITED STATES on Aug 02, 2005. Female patient, 84 years of age, weighting 118.8 lb, was diagnosed with angiogram and was treated with Visipaque. After drug was administered, patient experienced the following side effects: dialysis , haemorrhage, hypotension, oliguria, post procedural complication, renal failure acute, renal tubular necrosis, retroperitoneal haemorrhage. Visipaque dosage: unknown. During the same period patient was treated with TYLENOL, VIT C, POTASSIUM CHLORIDE, LASIX, CARDIZEM, QUININE SULPHATE, TRICOR, COUMADIN. Patient was hospitalized. Patient recovered.


Visipaque Side Effects Report #4916424-X
Visipaque side effect was reported by a Consumer or non-health professional from SWITZERLAND on Feb 10, 2006. Female patient, 71 years of age, weighting 136.7 lb, was treated with Visipaque. After drug was administered, patient experienced the following side effects: accident, post procedural complication, syncope. Visipaque dosage: unknown. Patient recovered.

Visipaque Side Effects Report #5015940-2
Visipaque side effect was reported by a Health Professional from UNITED STATES on May 31, 2006. Male patient, 53 years of age, weighting 250.0 lb, was treated with Visipaque. After drug was administered, patient experienced the following side effects: post procedural complication, pruritus, rash maculo-papular. Visipaque dosage: unknown. Patient recovered.